Home ›
Entities
› academia
› End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma
End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma
Research article (Quantitative Imaging in Medicine and Surgery, 2023) · cited 11× · AI/ML
End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma
Summary
End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma is a scholarly article[1].
Key Facts
End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma. Retrieved May 24, 2026, from https://4ort.xyz/entity/end-to-end-deep-learning-radiomics-development-and-validation-of-a-novel-attention-based-aggregate-convolutional-neural-
MLA“End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/end-to-end-deep-learning-radiomics-development-and-validation-of-a-novel-attention-based-aggregate-convolutional-neural-.
BibTeX@misc{4ortxyz_end-to-end-deep-learning-radiomics-development-and-validation-of-a-novel-attention-based-aggregate-convolutional-neural-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma}}, year = {2026}, url = {https://4ort.xyz/entity/end-to-end-deep-learning-radiomics-development-and-validation-of-a-novel-attention-based-aggregate-convolutional-neural-}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma — https://4ort.xyz/entity/end-to-end-deep-learning-radiomics-development-and-validation-of-a-novel-attention-based-aggregate-convolutional-neural- (retrieved 2026-05-24)